Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2019. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3761721010 | Calcium carbonate 800 mg and famotidine 10 mg and magnesium hydroxide 165 mg chewable tablet | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3761722015 | Product containing precisely calcium carbonate 800 milligram and famotidine 10 milligram and magnesium hydroxide 165 milligram/1 each conventional release chewable tablet (clinical drug) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Calcium carbonate 800 mg and famotidine 10 mg and magnesium hydroxide 165 mg chewable tablet | Has presentation strength denominator unit (attribute) | Tablet (unit of presentation) | true | Inferred relationship | Some | 1 | |
| Calcium carbonate 800 mg and famotidine 10 mg and magnesium hydroxide 165 mg chewable tablet | Count of base of active ingredient | trois | false | Inferred relationship | Some | ||
| Calcium carbonate 800 mg and famotidine 10 mg and magnesium hydroxide 165 mg chewable tablet | Plays role | Laxative therapeutic role | true | Inferred relationship | Some | ||
| Calcium carbonate 800 mg and famotidine 10 mg and magnesium hydroxide 165 mg chewable tablet | Has presentation strength denominator value | un | false | Inferred relationship | Some | 1 | |
| Calcium carbonate 800 mg and famotidine 10 mg and magnesium hydroxide 165 mg chewable tablet | Has presentation strength numerator unit | milligram (qualifier value) | true | Inferred relationship | Some | 2 | |
| Calcium carbonate 800 mg and famotidine 10 mg and magnesium hydroxide 165 mg chewable tablet | Has presentation strength denominator unit (attribute) | Tablet (unit of presentation) | true | Inferred relationship | Some | 3 | |
| Calcium carbonate 800 mg and famotidine 10 mg and magnesium hydroxide 165 mg chewable tablet | Has presentation strength denominator value | un | false | Inferred relationship | Some | 2 | |
| Calcium carbonate 800 mg and famotidine 10 mg and magnesium hydroxide 165 mg chewable tablet | Has presentation strength denominator value | un | false | Inferred relationship | Some | 3 | |
| Calcium carbonate 800 mg and famotidine 10 mg and magnesium hydroxide 165 mg chewable tablet | Has unit of presentation | Tablet (unit of presentation) | true | Inferred relationship | Some | ||
| Calcium carbonate 800 mg and famotidine 10 mg and magnesium hydroxide 165 mg chewable tablet | Has presentation strength numerator unit | milligram (qualifier value) | true | Inferred relationship | Some | 3 | |
| Calcium carbonate 800 mg and famotidine 10 mg and magnesium hydroxide 165 mg chewable tablet | Has presentation strength denominator unit (attribute) | Tablet (unit of presentation) | true | Inferred relationship | Some | 2 | |
| Calcium carbonate 800 mg and famotidine 10 mg and magnesium hydroxide 165 mg chewable tablet | Has presentation strength numerator unit | milligram (qualifier value) | true | Inferred relationship | Some | 1 | |
| Calcium carbonate 800 mg and famotidine 10 mg and magnesium hydroxide 165 mg chewable tablet | est un(e) (attribut) | Product containing only calcium carbonate and famotidine and magnesium hydroxide in oral dose form (medicinal product form) | true | Inferred relationship | Some | ||
| Calcium carbonate 800 mg and famotidine 10 mg and magnesium hydroxide 165 mg chewable tablet | Has basis of strength substance (attribute) | Magnesium hydroxide (substance) | true | Inferred relationship | Some | 3 | |
| Calcium carbonate 800 mg and famotidine 10 mg and magnesium hydroxide 165 mg chewable tablet | Has precise active ingredient | Magnesium hydroxide (substance) | true | Inferred relationship | Some | 3 | |
| Calcium carbonate 800 mg and famotidine 10 mg and magnesium hydroxide 165 mg chewable tablet | Has precise active ingredient | Famotidine (substance) | true | Inferred relationship | Some | 1 | |
| Calcium carbonate 800 mg and famotidine 10 mg and magnesium hydroxide 165 mg chewable tablet | Has presentation strength numerator value (attribute) | dix | false | Inferred relationship | Some | 1 | |
| Calcium carbonate 800 mg and famotidine 10 mg and magnesium hydroxide 165 mg chewable tablet | Has precise active ingredient | Calcium carbonate (substance) | true | Inferred relationship | Some | 2 | |
| Calcium carbonate 800 mg and famotidine 10 mg and magnesium hydroxide 165 mg chewable tablet | Has basis of strength substance (attribute) | Famotidine (substance) | true | Inferred relationship | Some | 1 | |
| Calcium carbonate 800 mg and famotidine 10 mg and magnesium hydroxide 165 mg chewable tablet | Has basis of strength substance (attribute) | Calcium carbonate (substance) | true | Inferred relationship | Some | 2 | |
| Calcium carbonate 800 mg and famotidine 10 mg and magnesium hydroxide 165 mg chewable tablet | Has presentation strength numerator value (attribute) | 165 (qualifier value) | false | Inferred relationship | Some | 3 | |
| Calcium carbonate 800 mg and famotidine 10 mg and magnesium hydroxide 165 mg chewable tablet | Has presentation strength numerator value (attribute) | 800 (qualifier value) | false | Inferred relationship | Some | 2 | |
| Calcium carbonate 800 mg and famotidine 10 mg and magnesium hydroxide 165 mg chewable tablet | est un(e) (attribut) | Product containing calcium carbonate and famotidine and magnesium hydroxide (medicinal product) | false | Inferred relationship | Some | ||
| Calcium carbonate 800 mg and famotidine 10 mg and magnesium hydroxide 165 mg chewable tablet | a pour principe actif (attribut) | Laxative (substance) | false | Inferred relationship | Some | ||
| Calcium carbonate 800 mg and famotidine 10 mg and magnesium hydroxide 165 mg chewable tablet | a pour principe actif (attribut) | Magnesium | false | Inferred relationship | Some | ||
| Calcium carbonate 800 mg and famotidine 10 mg and magnesium hydroxide 165 mg chewable tablet | a pour principe actif (attribut) | Trace element supplementation (substance) | false | Inferred relationship | Some | ||
| Calcium carbonate 800 mg and famotidine 10 mg and magnesium hydroxide 165 mg chewable tablet | a pour principe actif (attribut) | Famotidine (substance) | false | Inferred relationship | Some | ||
| Calcium carbonate 800 mg and famotidine 10 mg and magnesium hydroxide 165 mg chewable tablet | a pour principe actif (attribut) | Magnesium hydroxide (substance) | false | Inferred relationship | Some | ||
| Calcium carbonate 800 mg and famotidine 10 mg and magnesium hydroxide 165 mg chewable tablet | a pour principe actif (attribut) | Magnesium-based antacid (substance) | false | Inferred relationship | Some | ||
| Calcium carbonate 800 mg and famotidine 10 mg and magnesium hydroxide 165 mg chewable tablet | a pour principe actif (attribut) | Calcium carbonate (substance) | false | Inferred relationship | Some | ||
| Calcium carbonate 800 mg and famotidine 10 mg and magnesium hydroxide 165 mg chewable tablet | a une forme pharmaceutique (attribut) | comprimé | false | Inferred relationship | Some | ||
| Calcium carbonate 800 mg and famotidine 10 mg and magnesium hydroxide 165 mg chewable tablet | a une forme pharmaceutique (attribut) | Oral tablet | false | Inferred relationship | Some | ||
| Calcium carbonate 800 mg and famotidine 10 mg and magnesium hydroxide 165 mg chewable tablet | est un(e) (attribut) | Famotidine-containing product in oral dose form | false | Inferred relationship | Some | ||
| Calcium carbonate 800 mg and famotidine 10 mg and magnesium hydroxide 165 mg chewable tablet | a une forme pharmaceutique (attribut) | Chewable tablet | true | Inferred relationship | Some | ||
| Calcium carbonate 800 mg and famotidine 10 mg and magnesium hydroxide 165 mg chewable tablet | est un(e) (attribut) | Product containing calcium carbonate in oral dose form (medicinal product form) | false | Inferred relationship | Some | ||
| Calcium carbonate 800 mg and famotidine 10 mg and magnesium hydroxide 165 mg chewable tablet | est un(e) (attribut) | TEMPORARY parent for CDs that are not updated | false | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets
Canada English language reference set (foundation metadata concept)
Description inactivation indicator reference set
FHIR